The DOI matches its Crossref record; 219 of the 219 references it cites were found in a registry or an index.
Polyethylene Glycol Immunogenicity: Theoretical, Clinical, and Practical Aspects of Anti-Polyethylene Glycol Antibodies
Open accessAbstract
Polyethylene glycol (PEG) is a flexible, hydrophilic simple polymer that is physically attached to peptides, proteins, nucleic acids, liposomes, and nanoparticles to reduce renal clearance, block antibody and protein binding sites, and enhance the half-life and efficacy of therapeutic molecules. Some naïve individuals have pre-existing antibodies that can bind to PEG, and some PEG-modified compounds induce additional antibodies against PEG, which can adversely impact drug efficacy and safety. Here we provide a framework to better understand PEG immunogenicity and how antibodies against PEG affect pegylated drug and nanoparticles. Analysis of published studies reveals rules for predicting accelerated blood clearance of pegylated medicine and therapeutic liposomes. Experimental studies of anti-PEG antibody binding to different forms, sizes, and immobilization states of PEG are also provided. The widespread use of SARS-CoV-2 RNA vaccines that incorporate PEG in lipid nanoparticles make understanding possible effects of anti-PEG antibodies on pegylated medicines even more critical.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL
Litinskiy, M. B., Nardelli, B., Hilbert, D. M., He, B., Schaffer, A., Casali, P., & Cerutti, A. (2002) · Nature Immunology · doi:10.1038/ni829 · Cited by 1,252
RetractedSafety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Polack, F. P., Thomas, S. J., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Perez, J. L., Pérez Marc, G., Moreira, E. D., Zerbini, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2034577 · Cited by 14,592
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792
PEGylation as a strategy for improving nanoparticle-based drug and gene delivery
Suk, J. S., Xu, Q., Kim, N., Hanes, J., & Ensign, L. M. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.09.012 · Cited by 4,523
PEGylation, successful approach to drug delivery
Veronese, F. M., & Pasut, G. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03575-0 · Cited by 2,339
Nanoparticle PEGylation for Imaging and Therapy
Jokerst, J. V., Lobovkina, T., Zare, R. N., & Gambhir, S. S. (2011) · Nanomedicine · doi:10.2217/nnm.11.19 · Cited by 2,046
Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes
Klibanov, A. L., Maruyama, K., Torchilin, V. P., & Huang, L. (1990) · FEBS Letters · doi:10.1016/0014-5793(90)81016-h · Cited by 2,027
T follicular helper cell differentiation, function, and roles in disease
Crotty, S. (2014) · Immunity · doi:10.1016/j.immuni.2014.10.004 · Cited by 1,847
MacLennan, I. C. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.immunol.12.1.117 · Cited by 1,729
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
Akinc, A., Maier, M. A., Manoharan, M., Fitzgerald, K., Jayaraman, M., Barros, S., Ansell, S., Du, X., Hope, M. J., Madden, T. D., et al. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0591-y · Cited by 1,636
Positive and negative selection of T cells
Starr, T. K., Jameson, S. C., & Hogquist, K. A. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141107 · Cited by 1,601
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Victora, G. D., Schwickert, T. A., Fooksman, D. R., Kamphorst, A. O., Meyer-Hermann, M., Dustin, M. L., & Nussenzweig, M. C. (2010) · Cell · doi:10.1016/j.cell.2010.10.032 · Cited by 1,238
Mol* Viewer: modern web app for 3D visualization and analysis of large biomolecular structures
Sehnal, D., Bittrich, S., Deshpande, M., Svobodová, R., Berka, K., Bazgier, V., Velankar, S., Burley, S. K., Koča, J., & Rose, A. S. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab314 · Cited by 1,154
Vinuesa, C. G., Linterman, M. A., Yu, D., & MacLennan, I. C. M. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-041015-055605 · Cited by 1,141
Mechanism and Regulation of Class Switch Recombination
Stavnezer, J., Guikema, J. E. J., & Schrader, C. E. (2008) · Annual Review of Immunology · doi:10.1146/annurev.immunol.26.021607.090248 · Cited by 1,132
Germinal Center B Cell Dynamics
Mesin, L., Ersching, J., & Victora, G. D. (2016) · Immunity · doi:10.1016/j.immuni.2016.09.001 · Cited by 994
Germinal-Center Organization and Cellular Dynamics
Allen, C. D. C., Okada, T., & Cyster, J. G. (2007) · Immunity · doi:10.1016/j.immuni.2007.07.009 · Cited by 983
B Cell Responses: Cell Interaction Dynamics and Decisions
Cyster, J. G., & Allen, C. D. C. (2019) · Cell · doi:10.1016/j.cell.2019.03.016 · Cited by 971
The double life of a B-1 cell: self-reactivity selects for protective effector functions
Baumgarth, N. (2011) · Nature Reviews Immunology · doi:10.1038/nri2901 · Cited by 969
Mackay, F., & Schneider, P. (2009) · Nature Reviews Immunology · doi:10.1038/nri2572 · Cited by 930
Poly(2‐oxazoline)s: A Polymer Class with Numerous Potential Applications
Hoogenboom, R. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901607 · Cited by 889
Martin, F., & Kearney, J. F. (2002) · Nature Reviews Immunology · doi:10.1038/nri799 · Cited by 860
Complement Is Activated by IgG Hexamers Assembled at the Cell Surface
Diebolder, C. A., Beurskens, F. J., de Jong, R. N., Koning, R. I., Strumane, K., Lindorfer, M. A., Voorhorst, M., Ugurlar, D., Rosati, S., Heck, A. J. R., et al. (2014) · Science · doi:10.1126/science.1248943 · Cited by 796
Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes
Cerutti, A., Cols, M., & Puga, I. (2013) · Nature Reviews Immunology · doi:10.1038/nri3383 · Cited by 777
Visualization of Specific B and T Lymphocyte Interactions in the Lymph Node
Garside, P., Ingulli, E., Merica, R. R., Johnson, J. G., Noelle, R. J., & Jenkins, M. K. (1998) · Science · doi:10.1126/science.281.5373.96 · Cited by 774
Puga, I., Cols, M., Barra, C. M., He, B., Cassis, L., Gentile, M., Comerma, L., Chorny, A., Shan, M., Xu, W., et al. (2012) · Nature Immunology · doi:10.1038/ni.2194 · Cited by 727
Armstrong, J. K., Hempel, G., Koling, S., Chan, L. S., Fisher, T., Meiselman, H. J., & Garratty, G. (2007) · Cancer · doi:10.1002/cncr.22739 · Cited by 699
Kozma, G. T., Shimizu, T., Ishida, T., & Szebeni, J. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.07.024 · Cited by 696
Anti-PEG antibodies in the clinic: Current issues and beyond PEGylation
Zhang, P., Sun, F., Liu, S., & Jiang, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.040 · Cited by 688
Oesterhelt, F., Rief, M., & Gaub, H. E. (1999) · New Journal of Physics · doi:10.1088/1367-2630/1/1/006 · Cited by 635
FDA-Approved Oligonucleotide Therapies in 2017
Stein, C. A., & Castanotto, D. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.023 · Cited by 608
Dams, E. T. M., Laverman, P., Oyen, W. J. G., Storm, G., Scherphof, G. L., van der Meer, J. W. M., Corstens, F. H. M., & Boerman, O. C. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35391-1 · Cited by 607
Anti‐ PEG immunity: emergence, characteristics, and unaddressed questions
Yang, Q., & Lai, S. K. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1339 · Cited by 593
Okada, T., Miller, M. J., Parker, I., Krummel, M. F., Neighbors, M., Hartley, S. B., O'Garra, A., Cahalan, M. D., & Cyster, J. G. (2005) · PLoS Biology · doi:10.1371/journal.pbio.0030150 · Cited by 585
Synthesis and release of B-lymphocyte stimulator from myeloid cells
Nardelli, B., Belvedere, O., Roschke, V., Moore, P. A., Olsen, H. S., Migone, T. S., Sosnovtseva, S., Carrell, J. A., Feng, P., Giri, J. G., et al. (2001) · Blood · doi:10.1182/blood.v97.1.198 · Cited by 576
Ishida, T., Ichihara, M., Wang, X., Yamamoto, K., Kimura, J., Majima, E., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.01.005 · Cited by 557
Immunogenicity of therapeutic proteins: Clinical implications and future prospects
Schellekens, H. (2002) · Clinical Therapeutics · doi:10.1016/s0149-2918(02)80075-3 · Cited by 556
Sheddable Coatings for Long-Circulating Nanoparticles
Romberg, B., Hennink, W. E., & Storm, G. (2008) · Pharmaceutical Research · doi:10.1007/s11095-007-9348-7 · Cited by 555
TACI and BAFF-R mediate isotype switching in B cells
Castigli, E., Wilson, S. A., Scott, S., Dedeoglu, F., Xu, S., Lam, K.-P., Bram, R. J., Jabara, H., & Geha, R. S. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20032000 · Cited by 544
Holmes, F. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.3.727 · Cited by 537
Bioequivalence and the immunogenicity of biopharmaceuticals
Schellekens, H. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd818 · Cited by 534
PEGylated liposomes: immunological responses
Mohamed, M., Abu Lila, A. S., Shimizu, T., Alaaeldin, E., Hussein, A., Sarhan, H. A., Szebeni, J., & Ishida, T. (2019) · Science and Technology of Advanced Materials · doi:10.1080/14686996.2019.1627174 · Cited by 523
Kitazawa, T., Igawa, T., Sampei, Z., Muto, A., Kojima, T., Soeda, T., Yoshihashi, K., Okuyama-Nishida, Y., Saito, H., Tsunoda, H., et al. (2012) · Nature Medicine · doi:10.1038/nm.2942 · Cited by 507
The pathophysiology of anaphylaxis
Reber, L. L., Hernandez, J. D., & Galli, S. J. (2017) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.06.003 · Cited by 507
The Membrane Attack Complex of Complement
Muller-Eberhard, H. J. (1986) · Annual Review of Immunology · doi:10.1146/annurev.iy.04.040186.002443 · Cited by 505
Pegylated interferon-α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data
Glue, P. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.110973 · Cited by 504
A Randomized Trial of Factor VIII and Neutralizing Antibodies in Hemophilia A
Peyvandi, F., Mannucci, P. M., Garagiola, I., El-Beshlawy, A., Elalfy, M., Ramanan, V., Eshghi, P., Hanagavadi, S., Varadarajan, R., Karimi, M., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516437 · Cited by 494
Chanan-Khan, A., Szebeni, J., Savay, S., Liebes, L., Rafique, N. M., Alving, C. R., & Muggia, F. M. (2003) · Annals of Oncology · doi:10.1093/annonc/mdg374 · Cited by 479
Fc‐fusion proteins: new developments and future perspectives
Czajkowsky, D. M., Hu, J., Shao, Z., & Pleass, R. J. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201201379 · Cited by 476
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
Schellenberger, V., Wang, C.-W., Geething, N. C., Spink, B. J., Campbell, A., To, W., Scholle, M. D., Yin, Y., Yao, Y., Bogin, O., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1588 · Cited by 462
Szebeni, J. (2014) · Molecular Immunology · doi:10.1016/j.molimm.2014.06.038 · Cited by 457
The BAFF/APRIL system: Emerging functions beyond B cell biology and autoimmunity
Vincent, F. B., Saulep-Easton, D., Figgett, W. A., Fairfax, K. A., & Mackay, F. (2013) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2013.04.003 · Cited by 445
Factor VIII Products and Inhibitor Development in Severe Hemophilia A
Gouw, S. C., van der Bom, J. G., Ljung, R., Escuriola, C., Cid, A. R., Claeyssens-Donadel, S., van Geet, C., Kenet, G., Mäkipernaa, A., Molinari, A. C., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208024 · Cited by 440
Szebeni, J., Muggia, F., Gabizon, A., & Barenholz, Y. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.06.017 · Cited by 423
Sazonovs, A., Kennedy, N. A., Moutsianas, L., Heap, G. A., Rice, D. L., Reppell, M., Bewshea, C. M., Chanchlani, N., Walker, G. J., Perry, M. H., et al. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.09.041 · Cited by 423
Safety assessment on polyethylene glycols (PEGs) and their derivatives as used in cosmetic products
Fruijtier-Pölloth, C. (2005) · Toxicology · doi:10.1016/j.tox.2005.06.001 · Cited by 407
Gessner, J. E., Heiken, H., Tamm, A., & Schmidt, R. E. (1998) · Annals of Hematology · doi:10.1007/s002770050396 · Cited by 404
Anaphylaxis: Lessons from mouse models
Finkelman, F. D. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.07.033 · Cited by 404
Maintaining safety with SARS-CoV-2 vaccines
Castells, M. C., & Phillips, E. J. (2021) · New England Journal of Medicine · doi:10.1056/nejmra2035343 · Cited by 395
Drummond, D. C., Noble, C. O., Guo, Z., Hong, K., Park, J. W., & Kirpotin, D. B. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4007 · Cited by 380
Yang, Q., Jacobs, T. M., McCallen, J. D., Moore, D. T., Huckaby, J. T., Edelstein, J. N., & Lai, S. K. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03437 · Cited by 370
Immediate‐type hypersensitivity to polyethylene glycols: a review
Wenande, E., & Garvey, L. H. (2016) · Clinical & Experimental Allergy · doi:10.1111/cea.12760 · Cited by 354
Stone, C. A., Liu, Y., Relling, M. V., Krantz, M. S., Pratt, A. L., Abreo, A., Hemler, J. A., & Phillips, E. J. (2019) · The Journal of Allergy and Clinical Immunology: In Practice · doi:10.1016/j.jaip.2018.12.003 · Cited by 351
Ganson, N. J., Kelly, S. J., Scarlett, E., Sundy, J. S., & Hershfield, M. S. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1861 · Cited by 350
He, B., Santamaria, R., Xu, W., Cols, M., Chen, K., Puga, I., Shan, M., Xiong, H., Bussel, J. B., Chiu, A., et al. (2010) · Nature Immunology · doi:10.1038/ni.1914 · Cited by 349
Schlapschy, M., Binder, U., Borger, C., Theobald, I., Wachinger, K., Kisling, S., Haller, D., & Skerra, A. (2013) · Protein Engineering Design and Selection · doi:10.1093/protein/gzt023 · Cited by 342
Chemistry for peptide and protein PEGylation
Roberts, M. J., Bentley, M. D., & Harris, J. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.025 · Cited by 334
Cao, Z., & Jiang, S. (2012) · Nano Today · doi:10.1016/j.nantod.2012.08.001 · Cited by 329
Dinndorf, P. A., Gootenberg, J., Cohen, M. H., Keegan, P., & Pazdur, R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-8-991 · Cited by 324
Heesters, B. A., Chatterjee, P., Kim, Y.-A., Gonzalez, S. F., Kuligowski, M. P., Kirchhausen, T., & Carroll, M. C. (2013) · Immunity · doi:10.1016/j.immuni.2013.02.023 · Cited by 300
Laverman, P., Carstens, M. G., Boerman, O. C., Th. M. Dams, E., Oyen, W. J. G., van Rooijen, N., Corstens, F. H. M., & Storm, G. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29419-2 · Cited by 298
Ishida, T., Atobe, K., Wang, X., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.017 · Cited by 287
Overcoming the Innate Immune Response to Small Interfering RNA
Judge, A., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.179 · Cited by 284
Wu, Y.-C., Kipling, D., Leong, H. S., Martin, V., Ademokun, A. A., & Dunn-Walters, D. K. (2010) · Blood · doi:10.1182/blood-2010-03-275859 · Cited by 283
Judge, A., McClintock, K., Phelps, J. R., & MacLachlan, I. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2005.09.014 · Cited by 280
Ganson, N. J., Povsic, T. J., Sullenger, B. A., Alexander, J. H., Zelenkofske, S. L., Sailstad, J. M., Rusconi, C. P., & Hershfield, M. S. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2015.10.034 · Cited by 273
Ishida, T., Ichihara, M., Wang, X., & Kiwada, H. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.001 · Cited by 270
Potential induction of anti-PEG antibodies and complement activation toward PEGylated therapeutics
Verhoef, J. J. F., Carpenter, J. F., Anchordoquy, T. J., & Schellekens, H. (2014) · Drug Discovery Today · doi:10.1016/j.drudis.2014.08.015 · Cited by 267
Hershfield, M. S., Ganson, N. J., Kelly, S. J., Scarlett, E. L., Jaggers, D. A., & Sundy, J. S. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4500 · Cited by 266
Lipsky, P. E., Calabrese, L. H., Kavanaugh, A., Sundy, J. S., Wright, D., Wolfson, M., & Becker, M. A. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4497 · Cited by 266
Hamad, I., Hunter, A. C., Szebeni, J., & Moghimi, S. M. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.08.276 · Cited by 253
B cell memory and the long-lived plasma cell
McHeyzer-Williams, M. G., & Ahmed, R. (1999) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)80029-6 · Cited by 246
Chen, B.-M., Su, Y.-C., Chang, C.-J., Burnouf, P.-A., Chuang, K.-H., Chen, C.-H., Cheng, T.-L., Chen, Y.-T., Wu, J.-Y., & Roffler, S. R. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03109 · Cited by 239
Self-citationFactor VIII inhibitors in hemophilia A: rationale and latest evidence
Witmer, C., & Young, G. (2013) · Therapeutic Advances in Hematology · doi:10.1177/2040620712464509 · Cited by 231
Richter, A. W., & Åkerblom, E. (1984) · International Archives of Allergy and Immunology · doi:10.1159/000233512 · Cited by 229
T cell help controls the speed of the cell cycle in germinal center B cells
Gitlin, A. D., Mayer, C. T., Oliveira, T. Y., Shulman, Z., Jones, M. J. K., Koren, A., & Nussenzweig, M. C. (2015) · Science · doi:10.1126/science.aac4919 · Cited by 223
Sundy, J. S., Ganson, N. J., Kelly, S. J., Scarlett, E. L., Rehrig, C. D., Huang, W., & Hershfield, M. S. (2007) · Arthritis & Rheumatism · doi:10.1002/art.22403 · Cited by 221
The Amplification Loop of the Complement Pathways
Lachmann, P. J. (2009) · Advances in Immunology · doi:10.1016/s0065-2776(08)04004-2 · Cited by 220
Szebeni, J., Bedőcs, P., Rozsnyay, Z., Weiszhár, Z., Urbanics, R., Rosivall, L., Cohen, R., Garbuzenko, O., Báthori, G., Tóth, M., et al. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.06.003 · Cited by 219
L-Asparaginase and PEG Asparaginase— Past, Present, and Future
Keating, M. J., Holmes, R., Lerner, S., & Ho, D. H. (1993) · Leukemia & Lymphoma · doi:10.3109/10428199309149129 · Cited by 217
B cells extract and present immobilized antigen: implications for affinity discrimination
Batista, F. D., & Neuberger, M. S. (2000) · The EMBO Journal · doi:10.1093/emboj/19.4.513 · Cited by 214
Kozma, G. T., Mészáros, T., Vashegyi, I., Fülöp, T., Örfi, E., Dézsi, L., Rosivall, L., Bavli, Y., Urbanics, R., Mollnes, T. E., et al. (2019) · ACS Nano · doi:10.1021/acsnano.9b03942 · Cited by 214
The crystal structure of human interferon β at 2.2-Å resolution
Karpusas, M., Nolte, M., Benton, C. B., Meier, W., Lipscomb, W. N., & Goelz, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.22.11813 · Cited by 211
Semple, S. C., Harasym, T. O., Clow, K. A., Ansell, S. M., Klimuk, S. K., & Hope, M. J. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.078113 · Cited by 211
Sandel, P. C., & Monroe, J. G. (1999) · Immunity · doi:10.1016/s1074-7613(00)80029-1 · Cited by 209
Mima, Y., Hashimoto, Y., Shimizu, T., Kiwada, H., & Ishida, T. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00144 · Cited by 209
Drolet, D. W., Nelson, J., Tucker, C. E., Zack, P. M., Nixon, K., Bolin, R., Judkins, M. B., Farmer, J. A., Wolf, J. L., Gill, S. C., et al. (2000) · Pharmaceutical Research · doi:10.1023/a:1007657109012 · Cited by 206
Menne, J., Eulberg, D., Beyer, D., Baumann, M., Saudek, F., Valkusz, Z., Więcek, A., Haller, H., & for the Emapticap Study Group (2017) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfv459 · Cited by 201
Povsic, T. J., Lawrence, M. G., Lincoff, A. M., Mehran, R., Rusconi, C. P., Zelenkofske, S. L., Huang, Z., Sailstad, J., Armstrong, P. W., Steg, P. G., et al. (2016) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2016.04.058 · Cited by 197
Accelerated Blood Clearance Phenomenon Upon Repeated Injection of PEG-modified PLA-nanoparticles
Ishihara, T., Takeda, M., Sakamoto, H., Kimoto, A., Kobayashi, C., Takasaki, N., Yuki, K., Tanaka, K.-I., Takenaga, M., Igarashi, R., et al. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9943-x · Cited by 195
Role of the methoxy group in immune responses to mPEG-protein conjugates
Sherman, M. R., Williams, L. D., Sobczyk, M. A., Michaels, S. J., & Saifer, M. G. P. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200551b · Cited by 185
Lincoff, A. M., Mehran, R., Povsic, T. J., Zelenkofske, S. L., Huang, Z., Armstrong, P. W., Steg, P. G., Bode, C., Cohen, M. G., Buller, C. E. H., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00515-2 · Cited by 167
Longo, N., Harding, C. O., Burton, B. K., Grange, D. K., Vockley, J., Wasserstein, M., Rice, G. M., Dorenbaum, A., Neuenburg, J. K., Musson, D. G., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61841-3 · Cited by 167
The Mystery of Antibodies Against Polyethylene Glycol (PEG) - What do we Know?
Lubich, C., Allacher, P., de la Rosa, M., Bauer, A., Prenninger, T., Horling, F. M., Siekmann, J., Oldenburg, J., Scheiflinger, F., & Reipert, B. M. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-1961-x · Cited by 164
Innate B cell helpers reveal novel types of antibody responses
Vinuesa, C. G., & Chang, P.-P. (2013) · Nature Immunology · doi:10.1038/ni.2511 · Cited by 159
Dintzis, R. Z., Okajima, M., Middleton, M. H., Greene, G., & Dintzis, H. M. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.143.4.1239 · Cited by 159
The tick-over theory revisited: Is C3 a contact-activated protein?
Nilsson, B., & Ekdahl, K. N. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.07.008 · Cited by 157
Alnylam launches era of RNAi drugs
Garber, K. (2018) · Nature Biotechnology · doi:10.1038/nbt0918-777 · Cited by 157
Rojko, J. L., Evans, M. G., Price, S. A., Han, B., Waine, G. J., DeWitte, M., Haynes, J. A., Freimark, B. D., Martin, P. L., Raymond, J. T., et al. (2014) · Toxicologic Pathology · doi:10.1177/0192623314526475 · Cited by 151
Particle size-dependent triggering of accelerated blood clearance phenomenon
Koide, H., Asai, T., Hatanaka, K., Urakami, T., Ishii, T., Kenjo, E., Nishihara, M., Yokoyama, M., Ishida, T., Kiwada, H., et al. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.06.004 · Cited by 149
Accelerated Clearance of Polyethylene Glycol-Modified Proteins by Anti-Polyethylene Glycol IgM
Cheng, T., Wu, P.-Y., Wu, M., Chern, J., & Roffler, S. R. (1999) · Bioconjugate Chemistry · doi:10.1021/bc980143z · Cited by 147
Self-citationShiraishi, K., Hamano, M., Ma, H., Kawano, K., Maitani, Y., Aoshi, T., Ishii, K. J., & Yokoyama, M. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.11.016 · Cited by 141
Surface De-PEGylation Controls Nanoparticle-Mediated siRNA Delivery In Vitro and In Vivo
Zhu, X., Tao, W., Liu, D. X., Wu, J., Guo, Z., Ji, X., Bharwani, Z., Zhao, L., Zhao, X., Farokhzad, O. C., et al. (2017) · Theranostics · doi:10.7150/thno.18136 · Cited by 139
Immunoglobulin flexibility in complement activation
Feinstein, A., Richardson, N. E., & Taussig, M. I. (1986) · Immunology Today · doi:10.1016/0167-5699(86)90168-4 · Cited by 136
Anti-PEG IgE in anaphylaxis associated with polyethylene glycol
Zhou, Z., Stone, C. A., Jakubovic, B. D., Phillips, E. J., Sussman, G., Park, J., Hoang, U., Kirshner, S., Levin, R. L., & Kozlowski, S. (2020) · The Journal of Allergy and Clinical Immunology In Practice · doi:10.1016/j.jaip.2020.11.011 · Cited by 134
Grenier, P., Viana, I. M. D. O., Lima, E. M., & Bertrand, N. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.08.022 · Cited by 133
Analytical Measurement of PEGylated Molecules
Cheng, T., Chuang, K.-H., Chen, B., & Roffler, S. R. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200478w · Cited by 131
Self-citationA Hard(y) look at B-1 cell development and function*
Baumgarth, N. (2017) · Journal of Immunology · doi:10.4049/jimmunol.1700943 · Cited by 131
Chen, E., Chen, B., Su, Y.-C., Chang, Y., Cheng, T., Barenholz, Y., & Roffler, S. R. (2020) · ACS Nano · doi:10.1021/acsnano.9b07218 · Cited by 131
Self-citationZhang, X., Goel, V., Attarwala, H. Z., Sweetser, M. T., Clausen, V. A., & Robbie, G. J. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1480 · Cited by 130
Suzuki, T., Ichihara, M., Hyodo, K., Yamamoto, E., Ishida, T., Kiwada, H., Ishihara, H., & Kikuchi, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.07.049 · Cited by 127
Size comparison between proteins PEGylated with branched and linear poly(ethylene glycol) molecules
Fee, C. J. (2007) · Biotechnology and Bioengineering · doi:10.1002/bit.21482 · Cited by 126
Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift
Cantor, J. R., Yoo, T. H., Dixit, A., Iverson, B. L., Forsthuber, T. G., & Georgiou, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1014739108 · Cited by 125
Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro
Neun, B. W., Barenholz, Y., Szebeni, J., & Dobrovolskaia, M. A. (2018) · Molecules · doi:10.3390/molecules23071700 · Cited by 122
Removing T-cell epitopes with computational protein design
King, C., Garza, E. N., Mazor, R., Linehan, J. L., Pastan, I. H., Pepper, M., & Baker, D. A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321126111 · Cited by 121
Ishida, T., Ichikawa, T., Ichihara, M., Sadzuka, Y., & Kiwada, H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.011 · Cited by 117
Repeated injections of PEG-PE liposomes generate anti-PEG antibodies.
Środa-Pomianek, K., Rydlewski, J., Langner, M., Kozubek, A., Grzybek, M., & Sikorski, A. F. (2005) · PubMed · Cited by 116
Saifer, M. G. P., Williams, L. D., Sobczyk, M. A., Michaels, S. J., & Sherman, M. R. (2013) · Molecular Immunology · doi:10.1016/j.molimm.2013.07.014 · Cited by 112
Anaphylaxis and anaphylactoid reactions: Classification and pathophysiology
Ring, J., & Behrendt, H. (1999) · Clinical Reviews in Allergy & Immunology · doi:10.1007/bf02737644 · Cited by 111
Povsic, T. J., Vavalle, J. P., Aberle, L. H., Kasprzak, J. D., Cohen, M. G., Mehran, R., Bode, C., Buller, C. E. H., Montalescot, G., Cornel, J. H., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs232 · Cited by 111
Hsieh, Y.-C., Wang, H.-E., Lin, W.-W., Roffler, S. R., Cheng, T.-C., Su, Y.-C., Li, J.-J., Chen, C., Huang, C.-H., Chen, B., et al. (2018) · Theranostics · doi:10.7150/thno.22164 · Cited by 111
Self-citationInterbilayer transfer of phospholipid-anchored macromolecules via monomer diffusion
Silvius, J. R., & Zuckermann, M. J. (1993) · Biochemistry · doi:10.1021/bi00063a030 · Cited by 106
Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
Frampton, J. E. (2020) · Drugs · doi:10.1007/s40265-020-01336-6 · Cited by 104
Immunogenicity of interferon beta: differences among products
Bertolotto, A., Deisenhammer, F., Gallo, P., & S�rensen, P. S. (2004) · Journal of Neurology · doi:10.1007/s00415-004-1204-7 · Cited by 103
Szebeni, J., Bedöcs, P., Urbanics, R., Bünger, R., Rosivall, L., Tóth, M., & Barenholz, Y. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.02.029 · Cited by 102
Steurer, M., Montillo, M., Scarfò, L., Mauro, F. R., Andel, J., Wildner, S. M., Trentin, L., Janssens, A. M., Burgstaller, S., Frömming, A., et al. (2019) · Haematologica · doi:10.3324/haematol.2018.205930 · Cited by 101
Dézsi, L., Fülöp, T., Mészáros, T., Szénási, G., Urbanics, R., Vázsonyi, C., Őrfi, E., Rosivall, L., Nemes, R., Kok, R. J., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.08.009 · Cited by 100
Platelets expressing IgG receptor FcγRIIA/CD32A determine the severity of experimental anaphylaxis
Beutier, H., Hechler, B., Godon, O., Wang, Y., Gillis, C. M., de Chaisemartin, L., Gouél‐Cheron, A., Magnenat, S., Macdonald, L. E., Murphy, A. J., et al. (2018) · Science Immunology · doi:10.1126/sciimmunol.aan5997 · Cited by 97
Cheng, T., Cheng, C., Chen, B., Tsao, D.-A., Chuang, K.-H., Hsiao, S.-W., Lin, Y.-H., & Roffler, S. R. (2005) · Bioconjugate Chemistry · doi:10.1021/bc050133f · Cited by 93
Self-citationThe Immune Response: Basic and Clinical Principles
Grayson, M. H. (2006) · Annals of Allergy Asthma & Immunology · doi:10.1016/s1081-1206(10)60028-2 · Cited by 93
Su, Y.-C., Chen, B., Chuang, K.-H., Cheng, T., & Roffler, S. R. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100067t · Cited by 93
Self-citationAntibodies Predict Pegaspargase Allergic Reactions and Failure of Rechallenge
Liu, Y., Smith, C. A., Panetta, J. C., Yang, W., Thompson, L. E., Counts, J. P., Molinelli, A. R., Pei, D., Kornegay, N. M., Crews, K. R., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02439 · Cited by 93
Shimizu, T., Mima, Y., Hashimoto, Y., Ukawa, M., Ando, H., Kiwada, H., & Ishida, T. (2015) · Immunobiology · doi:10.1016/j.imbio.2015.06.005 · Cited by 91
Shimizu, T., Lila, A. S. A., Fujita, R., Awata, M., Kawanishi, M., Hashimoto, Y., Okuhira, K., Ishima, Y., & Ishida, T. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.02.019 · Cited by 91
Different roles of D‐amino acids in immune phenomena
Seia, M., & Zisman, E. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.6.9194525 · Cited by 90
Shiraishi, K., Kawano, K., Maitani, Y., Aoshi, T., Ishii, K. J., Sanada, Y., Mochizuki, S., Sakurai, K., & Yokoyama, M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.05.010 · Cited by 87
McSweeney, M. D., Wessler, T., Price, L., Ciociola, E. C., Herity, L. B., Piscitelli, J. A., Zamboni, W. C., Forest, M. G., Cao, Y., & Lai, S. K. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.06.002 · Cited by 87
IgM memory B cells: a mouse/human paradox
Reynaud, C., Descatoire, M., Dogan, I., Huetz, F., Weller, S., & Weill, J. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0971-z · Cited by 86
Shimizu, T., Ishida, T., & Kiwada, H. (2012) · Immunobiology · doi:10.1016/j.imbio.2012.08.274 · Cited by 85
Structure of an anti-PEG antibody reveals an open ring that captures highly flexible PEG polymers
Huckaby, J. T., Jacobs, T. M., Li, Z., Perna, R. J., Wang, A., Nicely, N. I., & Lai, S. K. (2020) · Communications Chemistry · doi:10.1038/s42004-020-00369-y · Cited by 83
Methoxy Polyethylene Glycol-Epoetin Beta
Curran, M. P., & McCormack, P. L. (2008) · Drugs · doi:10.2165/00003495-200868080-00009 · Cited by 81
Wei, X., Shamrakov, D., Sioma, N., Peretz-Damari, S., Nativ‐Roth, E., Regev, O., & Barenholz, Y. (2018) · ACS Omega · doi:10.1021/acsomega.7b01235 · Cited by 77
Gupta, S., Lau, K., Harding, C. O., Shepherd, G. M., Boyer, R., Atkinson, J. P., Knight, V., Olbertz, J., Larimore, K., Gu, Z., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.10.038 · Cited by 77
Kaminskas, L. M., McLeod, V. M., Porter, C. J. H., & Boyd, B. J. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22682 · Cited by 76
Su, Y.-C., Burnouf, P., Chuang, K.-H., Chen, B., Cheng, T., & Roffler, S. R. (2017) · Nature Communications · doi:10.1038/ncomms15507 · Cited by 76
Self-citationSuzuki, T., Ichihara, M., Hyodo, K., Yamamoto, E., Ishida, T., Kiwada, H., Kikuchi, H., & Ishihara, H. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.09.047 · Cited by 75
Zhao, Y., Wang, C., Wang, L., Yang, Q., Tang, W., She, Z., & Deng, Y. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.04.023 · Cited by 71
Rau, R. E., Dreyer, Z. E., Choi, M. R., Wei, L., Skowroński, R., Allamneni, K. P., Devidas, M., Raetz, E. A., Adamson, P. C., Blaney, S. M., et al. (2017) · Pediatric Blood & Cancer · doi:10.1002/pbc.26873 · Cited by 70
Chang, C.-J., Chen, C.-H., Chen, B., Su, Y.-C., Chen, Y., Hershfield, M. S., Lee, M. M., Chen, Y.-T., Chen, Y.-T., Roffler, S. R., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00622-4 · Cited by 68
Self-citationCheng, T., Chen, B., Chern, J., Wu, M., & Roffler, S. R. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990147j · Cited by 67
Self-citationHenry, C. E., Wang, Y.-Y., Yang, Q., Hoang, T., Chattopadhyay, S., Hoen, T. E., Ensign, L. M., Nunn, K. L., Schroeder, H. A., McCallen, J., et al. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.07.019 · Cited by 67
Self-citationSpecific TLR ligands regulate APRIL secretion by dendritic cells in a PKR‐dependent manner
Hardenberg, G., Planelles, L., Schwarte, C. M., van Bostelen, L., Hương, T. L. T., Hahne, M., & Medema, J. P. (2007) · European Journal of Immunology · doi:10.1002/eji.200737210 · Cited by 66
Moghimi, S. M., Simberg, D., Skotland, T., Yaghmur, A., & Hunter, A. C. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.119.258012 · Cited by 66
Hypersensitivity to Polyethylene Glycols
Shah, S., Prematta, T., Adkinson, N. F., & Ishmael, F. T. (2012) · The Journal of Clinical Pharmacology · doi:10.1177/0091270012447122 · Cited by 65
Comparison of in vitro antibody-targeted cytotoxicity using mouse, rat and human effectors
Bergman, I., Basse, P. H., Barmada, M. A., Griffin, J. A., & Cheung, N. V. (2000) · Cancer Immunology Immunotherapy · doi:10.1007/s002620000120 · Cited by 65
Hashimoto, Y., Shimizu, T., Lila, A. S. A., Ishida, T., & Kiwada, H. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b14-00653 · Cited by 65
Liu, Y., Reidler, H., Pan, J., Milunic, D., Qin, D., Chen, D., Vallejo, R. P., & Yin, R. (2011) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2011.07.003 · Cited by 64
Yu, D. S., Wang, D., Zhu, F., Bhagat, L., Dai, M., Kandimalla, E. R., & Agrawal, S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900730r · Cited by 64
Structural basis of polyethylene glycol recognition by antibody
Lee, C., Su, Y.-C., Ko, T., Lin, L., Yang, C.-Y., Chang, S. S.-C., Roffler, S. R., & Wang, A. H. ‐. (2020) · Journal of Biomedical Science · doi:10.1186/s12929-019-0589-7 · Cited by 61
Self-citationLee, Y.-J., Urban, J. H., Xu, L., Sullenger, B. A., & Lee, J. (2016) · Nucleic Acid Therapeutics · doi:10.1089/nat.2015.0575 · Cited by 60
Fix, S. M., Nyankima, A. G., McSweeney, M. D., Tsuruta, J. K., Lai, S. K., & Dayton, P. A. (2018) · Ultrasound in Medicine & Biology · doi:10.1016/j.ultrasmedbio.2018.02.006 · Cited by 60
Anaphylaxis and Hypotension after Administration of Peginesatide
Bennett, C. L., Jacob, S., Hymes, J., Usvyat, L. A., & Maddux, F. W. (2014) · New England Journal of Medicine · doi:10.1056/nejmc1400883 · Cited by 59
Potential Capacity of Aptamers to Trigger Immune Activation in Human Blood
Avci‐Adali, M., Steinle, H., Michel, T., Schlensak, C., & Wendel, H. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068810 · Cited by 59
Bavli, Y., Winkler, I., Chen, B. M., Roffler, S. R., Cohen, R., Szebeni, J., & Barenholz, Y. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.06.007 · Cited by 59
Self-citationKao, C.-H., Wang, J., Chuang, K.-H., Chuang, C., Cheng, T.-C., Hsieh, Y.-C., Tseng, Y., Chen, B., Roffler, S. R., & Cheng, T.-L. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.08.032 · Cited by 58
Self-citationNishio, A., Bolte, F. J., Takeda, K., Park, N., Yu, Z., Park, H., Valdez, K., Ghany, M. G., & Rehermann, B. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.aba6322 · Cited by 58
Koide, H., Asai, T., Kato, H., Ando, H., Shiraishi, K., Yokoyama, M., & Oku, N. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.04.049 · Cited by 57
Li, C., Cao, J., Wang, Y., Zhao, X., Deng, C., Wei, N., Yang, J., & Cui, J. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23254 · Cited by 57
Hattori, Y., Tamaki, K., Sakasai, S., Ozaki, K., & Onishi, H. (2020) · Molecular Medicine Reports · doi:10.3892/mmr.2020.11525 · Cited by 56
Deng, Y., Yang, P., Ma, Zhao, She, Wang, Li, X., & Wang (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s41701 · Cited by 54
Progress in modulating the RBC membrane to produce transfusable universal/stealth donor RBCs
Garratty, G. (2004) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2004.06.005 · Cited by 54
Khalil, A., Würthwein, G., Golitsch, J., Hempel, G., Fobker, M., Gerß, J., Möricke, A., Zimmermann, M., Smíšek, P., Zucchetti, M., et al. (2020) · Haematologica · doi:10.3324/haematol.2020.258525 · Cited by 54
Peginesatide for the treatment of anemia due to chronic kidney disease – an unfulfilled promise
Hermanson, T., Bennett, C. L., & Macdougall, I. C. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1218467 · Cited by 51
Lila, A. S. A., Uehara, Y., Ishida, T., & Kiwada, H. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23823 · Cited by 49
Højfeldt, S. G., Wolthers, B. O., Tulstrup, M., Abrahamsson, J., Gupta, R., Harila‐Saari, A. H., Heyman, M. M., Henriksen, L. T., Jónsson, Ó. G., Lähteenmäki, P. M., et al. (2018) · British Journal of Haematology · doi:10.1111/bjh.15660 · Cited by 48
Hasan, H., Shaikh, O. M., Rassekh, S. R., Howard, A. F., & Goddard, K. (2016) · Pediatric Blood & Cancer · doi:10.1002/pbc.26200 · Cited by 47
Physician Awareness of Immune Responses to Polyethylene Glycol‐Drug Conjugates
McSweeney, M. D., Versfeld, Z., Carpenter, D. M., & Lai, S. K. (2018) · Clinical and Translational Science · doi:10.1111/cts.12537 · Cited by 44
Oligodeoxyribonucleotide-Based Antagonists for Toll-Like Receptors 7 and 9
Wang, D., Bhagat, L., Yu, D. S., Zhu, F., Tang, J. X., Kandimalla, E. R., & Agrawal, S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm8014316 · Cited by 43
Li, C., Zhao, X., Wang, Y., Yang, H., Li, H., Li, H., Tian, W., Yang, J., & Cui, J. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.01.012 · Cited by 43
Sylvestre, M., Lv, S., Yang, L. F., Luera, N., Peeler, D. J., Chen, B., Roffler, S. R., & Pun, S. H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.01.015 · Cited by 42
Self-citationCui, J., Li, C., Wang, C., Li, Y., Zhang, L., Zhang, L., & Yang, H. (2008) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.60.12.0011 · Cited by 41
Probable anaphylactic reaction to polyethylene glycol electrolyte lavage solution
Schuman, E., & Balsam, P. E. (1991) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(91)70761-x · Cited by 40
Huang, W.-C., Burnouf, P., Su, Y.-C., Chen, B., Chuang, K., Lee, C., Wei, P., Cheng, T., & Roffler, S. R. (2016) · ACS Nano · doi:10.1021/acsnano.5b05661 · Cited by 40
Self-citationLila, A. S. A., Eldin, N. E., Ichihara, M., Ishida, T., & Kiwada, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.08.030 · Cited by 39
Nagao, A., Lila, A. S. A., Ishida, T., & Kiwada, H. (2012) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.11.015 · Cited by 39
Angioedema from oral polyethylene glycol electrolyte lavage solution
Stollman, N., & Manten, H. D. (1996) · Gastrointestinal Endoscopy · doi:10.1016/s0016-5107(96)70150-5 · Cited by 37
Cheng, Y., Chen, I., Su, Y.-C., Cheng, K.-W., Lu, Y., Lin, W.-W., Hsieh, Y.-C., Kao, C.-H., Chen, F., Roffler, S. R., et al. (2019) · Biomaterials Science · doi:10.1039/c9bm00323a · Cited by 36
Self-citation
Cited by
Anti-PEG Antibodies Boosted in Humans by SARS-CoV-2 Lipid Nanoparticle mRNA Vaccine
Ju, Y., Lee, W. S., Pilkington, E. H., Kelly, H. G., Li, S., Selva, K. J., Wragg, K. M., Subbarao, K., Nguyen, T. H. O., Rowntree, L. C., et al. (2022) · ACS Nano · doi:10.1021/acsnano.2c04543 · Cited by 372
PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective
Tenchov, R., Sasso, J. M., & Zhou, Q. A. (2023) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.3c00174 · Cited by 313
Lipid nanoparticles for delivery of RNA therapeutics: Current status and the role of in vivo imaging
Jung, H. N., Lee, S.-Y., Lee, S., Youn, H., & Im, H.-J. (2022) · Theranostics · doi:10.7150/thno.77259 · Cited by 282
Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines
Ju, Y., Carreño, J. M., Simon, V., Dawson, K., Krammer, F., & Kent, S. J. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-022-00825-x · Cited by 201
The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Qian, L., Lin, X., Gao, X., Khan, R. U., Liao, J.-Y., Du, S., Ge, J., Zeng, S., & Yao, S. Q. (2023) · Chemical Reviews · doi:10.1021/acs.chemrev.2c00915 · Cited by 155
Metadata
- Authors
- Chen, B.-M., Cheng, T.-L., & Roffler, S. R.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-09-01
- Volume
- 15
- Issue
- 9
- Pages
- 14022-14048
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W3198884354
- Cited by
- 563
- References
- 219
- FWCI
- 15.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.